"When you look at the IT program, we continue to await the animal data, which we expect to have in the middle of this year to the back half of this year, to remove the partial clinical hold if the data is \u2013 confirms the safety profile. We are working with the FDA to finalize the design of a pivotal confirmatory study, which we would then rapidly plan on implementing. We continue to progress our 10 early stage programs in gene therapies with 2 INDs and clinical trial starts planned in 2021."